LY2189102

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Arthritis, RheumatoidType 2 Diabetes

Phase 1

A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

CompletedNCT00380744

Eli Lilly and CompanyArthritis, Rheumatoid

Start: 2005-11-30End: 2007-11-30Updated: 2019-02-06

Phase 2

A Study of LY2189102 in Patients With Type 2 Diabetes

CompletedNCT00942188

Eli Lilly and CompanyType 2 Diabetes

Start: 2009-06-30End: 2010-11-30Updated: 2019-09-18